Pharmacotherapeutics for Advanced Practice Nurse
wi wi wi wi w i
Prescribers 5th Edition Woo Robinson Test Bank
w i i w i i w i i
PharmacotherapeuticswforwAdvancedwPracticewNursewPrescribersw5thwEditionwWoowRobinsonwTestwB
ank
Chapterw1.wThewRolewofwthewNursew
PractitionerwMultiplewChoice
Identifywthewchoicewthatw bestwcompleteswthewstatementworwanswerswthew question.
1.w Nursew practitionerw prescriptivew authorityw isw regulatedw by:
1. ThewNationalwCouncilwofwStatewBoardswofw Nursing
2. Thew U.S.w Drugw Enforcementw Administration
3. ThewStatew Boardw ofw Nursingw forw eachwstate
4. Thew Statew Boardw ofw Pharmacy
2.w Thew benefitsw tow thew patientw ofw havingw anw Advancedw Practicew Registeredw N
ursew (APRN)wprescriberwinclude:
1. NurseswknowwmorewaboutwPharmacologywthanwotherwprescriberswbecau
sewtheywtakewitwbothwinwtheirwbasicwnursingwprogramwandwinwtheirwAPR
Nwprogram.
2. Nurseswcarewforwthew patientw fromwaw holisticwapproachwandwincludew th
ewpatientwinw decisionw makingw regardingw theirw care.
3. APRNsw arew lessw likelyw tow prescribew narcoticsw andw otherw controlledw substances.
4. APRNswarewablew towprescribewindependentlywinwallwstates,wwhereaswawphysician’s
assistantw needsw tow havew aw physicianw supervisingw theirw practice.
3.w Clinicalw judgmentw inw prescribingw includes:
1. Factoringw inw thew costw tow thew patientw ofw thew medicationw prescribed
2. Alwaysw prescribingw thew newestw medicationw availablew forw thew diseasew process
3. Handingwoutw drugw samplesw towpoorw patients
4. Prescribingw allw genericw medicationsw tow cutw costs
4.w Criteriaw forw choosingw anw effectivew drugw forw aw disorderw include:
1. Askingwthewpatientwwhatwdrugw theyw thinkwwouldwworkwbestw forw them
2. Consultingwnationallywrecognizedw guidelineswforw diseasew management
3. Prescribingw medicationsw thatw arew availablew asw samplesw beforew writingw aw prescription
4. FollowingwU.S.wDrugwEnforcementwAdministrationwguidelineswforwprescribing
5.w Nursew practitionerw practicew mayw thrivew underw health-carew reformw becausew of:
1. Thewdemonstratedwabilitywofwnursewpractitionerswtowcontrolwcostswand
wimprovewpatientwoutcomes
2. Thew factw thatw nursew practitionersw willw bew ablew tow practicew independently
3. Thewfactwthatwnursewpractitionerswwillwhavewfullwreimbursementwunder
w health-carewreform
4. Thew abilityw tow shiftw accountabilityw forw Medicaidw tow thew statew level
,Pharmacotherapeutics for Advanced Practice Nurse
wi wi wi wi w i
Prescribers 5th Edition Woo Robinson Test Bank
w i i w i i w i i
, Pharmacotherapeutics for Advanced Practice Nurse wi wi wi wi w i
Prescribers 5th Edition Woo Robinson Test Bank
w i i w i i w i i
Chapterw1.wThewRolewofwthewNursew
PractitionerwAnswerwSection
MULTIPLEwCHOICE
1.wANS: 3 PTS: 1
2.wANS: 2 PTS: 1
3.wANS: 1 PTS: 1
4.wANS: 2 PTS: 1
5.wANS: 1 PTS: 1
Chapterw2.wReviewwofwBasicwPrincipleswofwPharmacologyw
MultiplewChoice
Identifywthewchoicewthatwbestwcompleteswthewstatementworw answerswthew question.
1.wAwpatient’swnutritionalwintakewandwlaboratorywresultswreflectwhypoalbuminemia.wThiswiswcritical
wtowprescribingwbecause:
1. Distributionwofw drugswtowtargetwtissuewmaywbewaffected.
2. Thewsolubilitywofw thewdrugw willwnotw matchw thewsitewofw absorption.
3. Therew willw bew lessw freew drugw availablew tow generatew anw effect.
4. Drugswboundw towalbuminwarewreadilywexcretedwbyw thewkidneys.
2.w Drugsw thatw havew aw significantw first-passw effect:
1. Mustw bew givenw byw thew enteralw (oral)w routew only
2. Bypassw thew hepaticw circulation
3. Arewrapidlywmetabolizedwbyw thewliverwandw mayw havewlittlew ifwanywdesiredwaction
4. Arew convertedw byw thew liverw tow morew activew andw fat-solublew forms
3.w Thew routew ofw excretionw ofw aw volatilew drugw willw likelyw bew the:
1. Kidneys
2. Lungs
3. Bilew andw feces
4. Skin
4.w Medroxyprogesteronew (Depow Provera)w isw prescribedw intramuscularlyw (I
M)w tow createwawstoragew reservoirw ofw thew drug.w Storagew reservoirs:
1. Assurew thatw thew drugw willw reachw itsw intendedw targetw tissue
2. Arewthewreasonw forw givingw loadingw doses
3. Increasew thewlengthw ofw timewawdrugw iswavailablewandw active
4. Arewmostwcommonwinwcollagenwtissues
5.wThewNPwchooseswtowgivewcephalexinw everyw 8w hoursw basedw onw knowledgew ofw thew drug’s:
1. Propensityw tow gow tow thew targetw receptor
2. Biologicalw half-life
, Pharmacotherapeutics for Advanced Practice Nurse
wi wi wi wi w i
Prescribers 5th Edition Woo Robinson Test Bank
w i i w i i w i i
3. Pharmacodynamics
4. Safetywandw sidew effects
wi wi wi wi w i
Prescribers 5th Edition Woo Robinson Test Bank
w i i w i i w i i
PharmacotherapeuticswforwAdvancedwPracticewNursewPrescribersw5thwEditionwWoowRobinsonwTestwB
ank
Chapterw1.wThewRolewofwthewNursew
PractitionerwMultiplewChoice
Identifywthewchoicewthatw bestwcompleteswthewstatementworwanswerswthew question.
1.w Nursew practitionerw prescriptivew authorityw isw regulatedw by:
1. ThewNationalwCouncilwofwStatewBoardswofw Nursing
2. Thew U.S.w Drugw Enforcementw Administration
3. ThewStatew Boardw ofw Nursingw forw eachwstate
4. Thew Statew Boardw ofw Pharmacy
2.w Thew benefitsw tow thew patientw ofw havingw anw Advancedw Practicew Registeredw N
ursew (APRN)wprescriberwinclude:
1. NurseswknowwmorewaboutwPharmacologywthanwotherwprescriberswbecau
sewtheywtakewitwbothwinwtheirwbasicwnursingwprogramwandwinwtheirwAPR
Nwprogram.
2. Nurseswcarewforwthew patientw fromwaw holisticwapproachwandwincludew th
ewpatientwinw decisionw makingw regardingw theirw care.
3. APRNsw arew lessw likelyw tow prescribew narcoticsw andw otherw controlledw substances.
4. APRNswarewablew towprescribewindependentlywinwallwstates,wwhereaswawphysician’s
assistantw needsw tow havew aw physicianw supervisingw theirw practice.
3.w Clinicalw judgmentw inw prescribingw includes:
1. Factoringw inw thew costw tow thew patientw ofw thew medicationw prescribed
2. Alwaysw prescribingw thew newestw medicationw availablew forw thew diseasew process
3. Handingwoutw drugw samplesw towpoorw patients
4. Prescribingw allw genericw medicationsw tow cutw costs
4.w Criteriaw forw choosingw anw effectivew drugw forw aw disorderw include:
1. Askingwthewpatientwwhatwdrugw theyw thinkwwouldwworkwbestw forw them
2. Consultingwnationallywrecognizedw guidelineswforw diseasew management
3. Prescribingw medicationsw thatw arew availablew asw samplesw beforew writingw aw prescription
4. FollowingwU.S.wDrugwEnforcementwAdministrationwguidelineswforwprescribing
5.w Nursew practitionerw practicew mayw thrivew underw health-carew reformw becausew of:
1. Thewdemonstratedwabilitywofwnursewpractitionerswtowcontrolwcostswand
wimprovewpatientwoutcomes
2. Thew factw thatw nursew practitionersw willw bew ablew tow practicew independently
3. Thewfactwthatwnursewpractitionerswwillwhavewfullwreimbursementwunder
w health-carewreform
4. Thew abilityw tow shiftw accountabilityw forw Medicaidw tow thew statew level
,Pharmacotherapeutics for Advanced Practice Nurse
wi wi wi wi w i
Prescribers 5th Edition Woo Robinson Test Bank
w i i w i i w i i
, Pharmacotherapeutics for Advanced Practice Nurse wi wi wi wi w i
Prescribers 5th Edition Woo Robinson Test Bank
w i i w i i w i i
Chapterw1.wThewRolewofwthewNursew
PractitionerwAnswerwSection
MULTIPLEwCHOICE
1.wANS: 3 PTS: 1
2.wANS: 2 PTS: 1
3.wANS: 1 PTS: 1
4.wANS: 2 PTS: 1
5.wANS: 1 PTS: 1
Chapterw2.wReviewwofwBasicwPrincipleswofwPharmacologyw
MultiplewChoice
Identifywthewchoicewthatwbestwcompleteswthewstatementworw answerswthew question.
1.wAwpatient’swnutritionalwintakewandwlaboratorywresultswreflectwhypoalbuminemia.wThiswiswcritical
wtowprescribingwbecause:
1. Distributionwofw drugswtowtargetwtissuewmaywbewaffected.
2. Thewsolubilitywofw thewdrugw willwnotw matchw thewsitewofw absorption.
3. Therew willw bew lessw freew drugw availablew tow generatew anw effect.
4. Drugswboundw towalbuminwarewreadilywexcretedwbyw thewkidneys.
2.w Drugsw thatw havew aw significantw first-passw effect:
1. Mustw bew givenw byw thew enteralw (oral)w routew only
2. Bypassw thew hepaticw circulation
3. Arewrapidlywmetabolizedwbyw thewliverwandw mayw havewlittlew ifwanywdesiredwaction
4. Arew convertedw byw thew liverw tow morew activew andw fat-solublew forms
3.w Thew routew ofw excretionw ofw aw volatilew drugw willw likelyw bew the:
1. Kidneys
2. Lungs
3. Bilew andw feces
4. Skin
4.w Medroxyprogesteronew (Depow Provera)w isw prescribedw intramuscularlyw (I
M)w tow createwawstoragew reservoirw ofw thew drug.w Storagew reservoirs:
1. Assurew thatw thew drugw willw reachw itsw intendedw targetw tissue
2. Arewthewreasonw forw givingw loadingw doses
3. Increasew thewlengthw ofw timewawdrugw iswavailablewandw active
4. Arewmostwcommonwinwcollagenwtissues
5.wThewNPwchooseswtowgivewcephalexinw everyw 8w hoursw basedw onw knowledgew ofw thew drug’s:
1. Propensityw tow gow tow thew targetw receptor
2. Biologicalw half-life
, Pharmacotherapeutics for Advanced Practice Nurse
wi wi wi wi w i
Prescribers 5th Edition Woo Robinson Test Bank
w i i w i i w i i
3. Pharmacodynamics
4. Safetywandw sidew effects
